Industry News
All Hill-Rom Holdings News
Top stories summarized by our editors
Top stories summarized by our editors

Hill-Rom enters $195M deal to buy Voalte

3/12/2019

Hill-Rom Holdings has agreed to pay $180 million upfront plus up to $15 million in commercial milestone payments for real-time, mobile health care communications firm Voalte. The acquisition is expected to be completed during Hill-Rom's fiscal third quarter.

CEO to retire from Hill-Rom

1/29/2018

John Greisch will retire from his position as CEO of Hill-Rom Holdings during the company's fiscal third quarter, which is the April-to-June time period. The search process for Greisch's replacement has begun and is expected to be finalized during that time.

Airway clearance system debuted by Hill-Rom

6/20/2016

The VisiVest System, a device intended to provide airway clearance therapy for patients with cystic fibrosis, has been launched by Hill-Rom Holdings. The vest is integrated into Qualcomm Life's 2net Hub, a connectivity solution that allows for transmission of data from the vest to Hill-Rom's VisiView Health Portal, enabling patients and care teams to view treatment trends and improve plans for individual care management.

Hill-Rom's $2.05B purchase of Welch Allyn completed

9/14/2015

Chicago-based medtech firm Hill-Rom Holdings has closed its $2.05 billion deal to purchase Welch Allyn, a maker of in vitro diagnostics products. Hill-Rom said the deal is expected to reduce customers' health care costs and help reach broader efficiency levels.

Hill-Rom's $2.05B purchase of Welch Allyn completed

9/10/2015

Chicago-based medtech firm Hill-Rom Holdings has closed its $2.05 billion deal to purchase Welch Allyn, a maker of in vitro diagnostics products. Hill-Rom said the deal is expected to reduce customers' health care costs and help reach broader efficiency levels.

Debt financing may bring in $425M for Hill-Rom

8/18/2015

A round of debt funding seeking to bring in $425 million has been launched by Chicago-based Hill-Rom Holdings. The firm aims to use the money to support its proposed acquisition of Welch Allyn and its point-of-care diagnostic device portfolio for $2.05 billion. The purchase is set to conclude on or before Sept. 30.

Hill-Rom acquisition of Welch Allyn approved by U.S. regulators

7/20/2015

The pending purchase of Welch Allyn and its line of point-of-care diagnostic devices by Hill-Rom Holdings for $2.05 billion has received approval from antitrust regulators in the U.S. The acquisition, which will give 13% of Hill-Rom shares to Welch Allyn shareholders, is on target to be completed by the end of September.

Hill-Rom acquisition of Welch Allyn approved by U.S. regulators

7/15/2015

The pending purchase of Welch Allyn and its line of point-of-care diagnostic devices by Hill-Rom Holdings for $2.05 billion has received approval from antitrust regulators in the U.S. The acquisition, which will give 13% of Hill-Rom shares to Welch Allyn shareholders, is on target to be completed by the end of September.